1 |
Sherman M. Hepatocellular carcinoma: epidemiology, surveil-lance, and diagnosis[J]. Semin Liver Dis, 2010, 30(1): 3-16.
|
2 |
Frenette C,Gish R. Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications[J]. World J Gastroenterol, 2012, 18(6): 498-506.
|
3 |
Cha CH,Saif MW,Yamane BH, et al. Hepatocellular carcinoma: current management[J]. Curr Probl Surg, 2010, 47(1): 10-67.
|
4 |
Hynes RO. Integrins: bidirectional, allosteric signaling machines[J]. Cell, 2002, 110(6): 673-687.
|
5 |
Guo W,Giancotti FG. Integrin signalling during tumour progres-sion[J]. Nat Rev Mol Cell Biol, 2004, 5(10): 816-826.
|
6 |
Zhang ZY,Xu KS,Wang JS, et al. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma[J]. Clin Oncol (R Coll Radiol), 2008, 20(1): 61-66.
|
7 |
Bates RC,Bellovin DI,Brown C, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition de-fines a novel prognostic indicator of aggressive colon carcinoma[J]. J Clin Invest, 2005, 115(2): 339-347.
|
8 |
Popov Y,Patsenker E,Stickel F, et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies[J]. J Hepatol, 2008, 48(3): 453-464.
|
9 |
Sipos B,Hahn D,Carceller A, et al. Immunohistochemical screen-ing for beta6-integrin subunit expression in adenocarcinomas us-ing a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro[J]. Histopa-thology, 2004, 45(3): 226-236.
|
10 |
Niu W,Liu X,Zhang Z, et al. Effects of alphavbeta6 gene silenc-ing by RNA interference in PANC-1 pancreatic carcinoma cells[J]. Anticancer Res, 2010, 30(1): 135-142.
|
11 |
Wang J,Wu J,Hong J, et al. PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of inte-grin αvβ6[J]. Cancer Lett, 2011, 311(1): 38-47.
|
12 |
Patsenker E,Wilkens L,Banz V, et al. The alphαvbeta6 integrin is a highly specific immunohistochemical marker for cholangiocar-cinoma[J]. J Hepatol, 2010, 52(3): 362-369.
|
13 |
Kitisin K,Ganesan N,Tang Y, et al. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation[J]. Oncogene, 2007, 26(50): 7103-7110.
|
14 |
Mills GB,Moolenaar WH. The emerging role of lysophosphatidic acid in cancer[J]. Nat Rev Cancer, 2003, 3(8): 582-591.
|
15 |
Miyazono K,Ehata S,Koinuma D. Tumor-promoting functions of transforming growth factor-β in progression of cancer[J]. Ups J Med Sci, 2012, 117(2): 143-152.
|
16 |
Jakowlew SB. Transforming growth factor-beta in cancer and me-tastasis[J]. Cancer Metastasis Rev, 2006, 25(3): 435-457.
|
17 |
Balzarini P,Benetti A,Invernici G, et al. Transforming growth fac-tor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocel-lular carcinoma[J]. Lab Invest, 2012, 92(9): 1297-1309.
|
18 |
Nakanaga K,Hama K,Aoki J. Autotaxin-an LPA producing en-zyme with diverse functions[J]. J Biochem, 2010, 148(1): 13-24.
|
19 |
Gotoh M,Fujiwara Y,Yue J, et al. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis[J]. Biochem Soc Trans, 2012, 40(1): 31-36.
|
20 |
Jiang Y,Xie X,Li Z, et al. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition[J]. Cancer Res, 2011, 71(8): 2959-2968.
|
21 |
Wu K,Ding J,Chen C, et al. Hepatic TGF-beta gives rise to tu-mor-initiating cells and promotes liver cancer development[J]. Hepatology, 2012, 56(6): 2255-2267.
|
22 |
Xu MY,Porte J,Knox AJ, et al. Lysophosphatidic acid induces alphαvbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q) [J]. Am J Pathol, 2009, 174(4): 1264-1279.
|
23 |
Geng H,Lan R,Singha PK, et al. Lysophosphatidic acid increas-es proximal tubule cell secretion of profibrotic cytokines PDGFB and CTGF through LPA2- and Galphaq-Mediated Rho and alphαvbeta6 integrin-dependent activation of TGF-beta[J]. Am J Pathol, 2012, 181(4): 1236-1249.
|
24 |
Sullivan BP,Weinreb PH,Violette SM, et al. The coagulation sys-tem contributes to alphαvbeta6 integrin expression and liver fi-brosis induced by cholestasis[J]. Am J Pathol, 2010, 177(6): 2837-2849.
|
25 |
许锐锐,韩慧,贺文静,等.整合素β6基因在HepG2细胞中主要转录调控区的定位分析[J/CD].中华普通外科学文献:电子版, 2013, 7(2): 96-100.
|